ProShares UltraShort Health Care
1 hedge funds and large institutions have $136K invested in ProShares UltraShort Health Care in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
141% more call options, than puts
Call options by funds: $53M | Put options by funds: $22M
17.97% less ownership
Funds ownership: 26.38% → 8.41% (-18%)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $279K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Old Mission Capital
Chicago,
Illinois
|
-$261K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18.3K |
RXD Hedge Fund Activity: Q1 2022 in Review
1 of the 6,362 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q1 2022, worth a combined $136K — down 67% from $406K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RXD and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Old Mission Capital, exiting entirely with an estimated $261K sold.
- 1 institutional investor held ProShares UltraShort Health Care (RXD) as of Q1 2022, down from 2 in Q4 2021.
- Funds reported $136K of ProShares UltraShort Health Care stock for Q1 2022, down 67% quarter-over-quarter.
- 0 funds opened new ProShares UltraShort Health Care positions in Q1 2022 and 1 closed out, a net change of -1 holder.
- The largest ProShares UltraShort Health Care seller in Q1 2022 was Old Mission Capital, an estimated $261K sold.
Based on aggregated 13F filings for Q1 2022.